Clinical Trials Directory

Trials / Completed

CompletedNCT02243709

Mifepristone for the Prevention of Relapses of Alcohol Drinking

A Pilot Study on the Safety and Efficacy of Mifepristone for the Prevention of Relapses of Alcohol Drinking

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to determine if, under stress, alcohol drinking is reduced using mifepristone

Conditions

Interventions

TypeNameDescription
DRUGMifepristone 600-mg/day or placebo for a week600-mg of mifepristone for a week, compared to placebo for a week, in a stress-induced condition triggered by a single dose of 32.4 mg of yohimbine

Timeline

Start date
2014-09-01
Primary completion
2021-12-21
Completion
2021-12-21
First posted
2014-09-18
Last updated
2025-01-10
Results posted
2023-06-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02243709. Inclusion in this directory is not an endorsement.

Mifepristone for the Prevention of Relapses of Alcohol Drinking (NCT02243709) · Clinical Trials Directory